Targeted Therapy Promising for Rare Hematologic Cancer
Tagraxofusp seems effective for treating blastic plasmacytoid dendritic-cell neoplasm
Hematology/Oncology
FDA approves new hemophilia A drug with factor VIII inhibitors
New FDA-approved prophylactic treatment decreases bleeding episodes hemophilia A patients with factor VIII inhibitors.
Ovarian cancer screening: a USPSTF recommendation statement
The USPSTF states that the harms of screening for ovarian cancer in asymptomatic women outweigh the benefits.
Breast, ovarian cancer risks estimated for BRCA1/BRCA2 mutation carriers
Breast cancer risk is increased with a larger number of first- and second-degree relatives diagnosed as having breast cancer for both BRCA1/BRCA2 carriers.
ASCO: Capecitabine may prolong survival in patients with biliary tract cancer
The researchers found that the average survival after surgery for those receiving capecitabine was longer compared with those who only had surgery.
One alcoholic drink per day may increase breast cancer risk
Drinking the equivalent of a small glass of wine or beer a day increases pre-menopausal breast cancer risk by 5% and post-menopausal breast cancer risk by 9%.
Low-dose aspirin reduces breast cancer risk
Developing breast cancer was associated inversely with taking 3 or more tablets of low-dose aspirin per week.
Metastatic pancreatic cancer: a new clinical practice guideline
The guideline will help clinicians determine the appropriate treatment of patients with metastatic pancreatic cancer.
An unusual pelvic mass in a 43-year-old woman
A woman who is in generally good health presents with a visibly enlarged abdomen with left-sided dominance and increased pelvic pressure that had worsened.
Additional weight may affect risk of gastrointestinal cancers
Excess weight could influence the risk of of gastrointestinal cancers by altering insulin levels and promoting inflammation.
Next post in Gastroenterology Information Center
